Edesa Biotech Inc (EDSA)


Stock Price Forecast

Feb. 21, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Edesa Biotech Inc chart...

About the Company

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases with clear unmet medical needs. The company's two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy that it's developing as a treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 patients. ARDS is a life-threatening form of respiratory failure, and the leading cause of death among COVID-19 patients. Edesa is also developing an sPLA2 inhibitor, designated as EB01, as a topical treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. The company is based in Markham, Ontario, Canada, with a U.S. subsidiary located in Southern California.

Employees

12

Exchange

NASDAQ

Website

www.edesabiotech.com

$0M

Total Revenue

12

Employees

$22M

Market Capitalization

-1.27

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $EDSA News

Edesa Biotech to Participate in HC Wainwright Autoimmune & Inflammatory Conference

7d ago, source:

TORONTO, ON / ACCESSWIRE / / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage biopharmaceutical company focused on ...

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

on MSN ago, source:

Last year was a tough one for biotech stocks. The Securities and Exchange Commission reported 41 bankruptcies following the ...

2 Top Biotech Buyout Candidates

3h ago, source:

ETFs like XBI and the iShares Biotech ETF (IBB) are the best instruments for risk-averse investors to take advantage of renewed interest in the sector while avoiding risky binary events like FDA ...

Biotech Stock News Bite - Elicio Therapeutics, Inc. (Nasdaq: ELTX) Rises on Funding News

9d ago, source: Investor ideas

Investorideas.com ( Biotech Stock News Bites - Elicio Therapeutics, Inc. (Nasdaq: ELTX), a clinical-stage biotechnology ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...